Cyclic peptidyl inhibitors of cal-pdz binding domain
AssigneeOhio State Innovation Foundation
InventorsDehua PEI, Patrick G. DOUGHERTY
Life of this patent
Estimating the term…
Loading patent…
AssigneeOhio State Innovation Foundation
InventorsDehua PEI, Patrick G. DOUGHERTY
Estimating the term…
Described herein, in various embodiments, are peptides comprising: (i) a cyclic cell-penetrating peptide sequence (cCPP) and (ii) a CAL-PDZ binding sequence, which is conjugated, directly or indirectly, to an N-terminus of an amino acid in the cCPP, to a C-terminus of an amino acid on the cCPP, or on a side chain of an amino acid in the cCPP. In other embodiments, the peptides further comprise a physiologically cleavable group, wherein after entering the cell, the physiologically cleavable group is reduced, thereby providing a linear peptide. Without being bound by theory, the inventors discovered that the amino acid sequence in the cCPP, which facilities cytosolic delivery of the CAL-PDZ binding sequence also, surprisingly and unexpectedly, synergistically improves binding of CAL-PDZ binding sequence to the CAL-PDZ binding domain. Additionally, the cCPP sequence may also improve selectivity of the CAL-PDZ binding sequence for the CAL-PDZ domain relative to other PDZ binding domains.
1-80. (canceled)
A peptide having a structure according to Formula I or II:
Dependencies are inferred from the claim text.